We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+45.33%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$361M
AUM Growth
+$24.6M
Cap. Flow
-$42.3M
Cap. Flow %
-11.73%
Top 10 Hldgs %
20.84%
Holding
153
New
45
Increased
24
Reduced
31
Closed
47

Top Buys

Rank Stock Value
1
CRDO icon
Credo Technology Group
CRDO
+$5.59M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$5.03M
3
MOD icon
Modine Manufacturing
MOD
+$4.87M
4
STRL icon
Sterling Infrastructure
STRL
+$4.85M
5
CELH icon
Celsius Holdings
CELH
+$4.47M

Top Sells

Rank Stock Value
1
PLMR icon
Palomar
PLMR
+$7.93M
2
CWST icon
Casella Waste Systems
CWST
+$6.98M
3
BTSG icon
BrightSpring Health Services
BTSG
+$6.21M
4
KRYS icon
Krystal Biotech
KRYS
+$5.48M
5
MASI
Masimo
MASI
+$5.08M

Sector Composition

Rank Sector Weight
1 Technology 26.37%
2 Industrials 25.9%
3 Healthcare 20.31%
4 Consumer Discretionary 10.72%
5 Consumer Staples 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIK icon
76
Viking Holdings
VIK
$47.5B
$1.78M 0.49%
33,320
– –
APLD icon
77
Applied Digital
APLD
$8.54B
$1.74M 0.48%
+172,365
New +$1.27M
LMB icon
78
Limbach Holdings
LMB
$586M
$1.71M 0.47%
+12,170
New +$1.38M
REVG
79
DELISTED
REV Group
REVG
$1.69M 0.47%
35,595
-5,200
-13% -$193K
EXAS
80
DELISTED
Exact Sciences
EXAS
$1.65M 0.46%
+31,060
New +$1.58M
LASR icon
81
nLIGHT
LASR
$4.3B
$1.6M 0.44%
+81,330
New +$1.01M
TTMI icon
82
TTM Technologies
TTMI
$15B
$1.55M 0.43%
+38,035
New +$1.05M
HURN icon
83
Huron Consulting
HURN
$2.39B
$1.55M 0.43%
11,240
-21,010
-65% -$2.99M
WSC icon
84
WillScot Mobile Mini Holdings
WSC
$4.74B
$1.53M 0.43%
+55,980
New +$1.49M
CFLT
85
DELISTED
Confluent
CFLT
$1.49M 0.41%
+59,845
New +$1.35M
CW icon
86
Curtiss-Wright
CW
$26.7B
$1.43M 0.4%
2,925
– –
WRBY icon
87
Warby Parker
WRBY
$3.19B
$1.37M 0.38%
+62,460
New +$1.15M
UEC icon
88
Uranium Energy
UEC
$5.31B
$1.34M 0.37%
+197,745
New +$1.11M
NVTS icon
89
Navitas Semiconductor
NVTS
$3.31B
$1.24M 0.34%
+189,945
New +$732K
LGND icon
90
Ligand Pharmaceuticals
LGND
$6.22B
$1.21M 0.34%
10,675
-41,900
-80% -$4.48M
CIEN icon
91
Ciena
CIEN
$58.1B
$1.18M 0.33%
14,465
– –
VKTX icon
92
Viking Therapeutics
VKTX
$3.89B
$1.14M 0.31%
+42,835
New +$1.13M
LENZ
93
LENZ Therapeutics
LENZ
$163M
$1.06M 0.29%
36,185
+10,520
+41% +$286K
JBL icon
94
Jabil
JBL
$36.2B
$1.03M 0.29%
4,715
+1,290
+38% +$209K
PEN icon
95
Penumbra
PEN
$12.8B
$1.03M 0.28%
4,005
– –
LOAR icon
96
Loar Holdings
LOAR
$6.87B
$1.02M 0.28%
+11,895
New +$1.03M
CYBR
97
DELISTED
CyberArk
CYBR
$936K 0.26%
2,300
-2,445
-52% -$891K
NAMS icon
98
NewAmsterdam Pharma
NAMS
$3.23B
$889K 0.25%
49,110
– –
FCFS icon
99
FirstCash
FCFS
$8.97B
$877K 0.24%
6,490
-4,895
-43% -$626K
GWRE icon
100
Guidewire Software
GWRE
$13.2B
$856K 0.24%
3,635
-16,570
-82% -$3.56M
2 3
4
5 6

Similar funds

PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return

Lisanti Capital Growth's Q2 2025 Portfolio in Review

As of Q2 2025, Lisanti Capital Growth held 153 positions worth $361M, up 7.3% from $336M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lisanti Capital Growth withdrew a net $42.3M in Q2 2025, closing 47 positions and reducing 31 holdings. Its most notable exit was Palomar, an estimated $7.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Tandem Diabetes Care worth $4.73M.

  • Lisanti Capital Growth's largest Q2 2025 buy was Tandem Diabetes Care: 253,840 shares worth $4.73M.
  • Lisanti Capital Growth added most to Credo Technology Group in Q2 2025, an estimated $5.59M increase.
  • Lisanti Capital Growth's biggest Q2 2025 reduction was Ligand Pharmaceuticals, cutting an estimated $4.48M.
  • Lisanti Capital Growth fully exited Palomar in Q2 2025, selling an estimated $7.93M.
  • Lisanti Capital Growth's ten largest holdings make up 21% of its $361M portfolio in Q2 2025.
  • Lisanti Capital Growth opened 45 new positions and closed 47 in Q2 2025.
  • Lisanti Capital Growth's portfolio value rose 7.3% quarter-over-quarter to $361M.

Based on Lisanti Capital Growth's 13F filing for Q2 2025, filed 7 Aug 2025.